Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.

× No keyword cloud information.

3 in total

Review 1. The clinical spectrum of pulmonary aspergillosis.

Authors: Ayman O Soubani; Pranatharthi H Chandrasekar
Journal: Chest Date: 2002-06 Impact factor: 9.410

2. Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

Authors: Jean-Baptiste Stern; Philippe Girard; Raffaele Caliandro
Journal: Antimicrob Agents Chemother Date: 2004-03 Impact factor: 5.191

3. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.

Authors: L Purkins; N Wood; P Ghahramani; K Greenhalgh; M J Allen; D Kleinermans
Journal: Antimicrob Agents Chemother Date: 2002-08 Impact factor: 5.191

3 in total

6 in total

1. Human tissue distribution of voriconazole.

Authors: Stefan Weiler; David Fiegl; Róisín MacFarland; Eva Stienecke; Rosa Bellmann-Weiler; Stefan Dunzendorfer; Michael Joannidis; Romuald Bellmann
Journal: Antimicrob Agents Chemother Date: 2010-11-15 Impact factor: 5.191

2. Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

Authors: Brad Moriyama; Marisa Ditullio; Eleanor Wilson; Stacey A Henning; Scott R Penzak; Robert L Danner; Gennethel Pennick; Michael G Rinaldi; Adrian M Zelazny; Juan Gea-Banacloche; A John Barrett; Thomas J Walsh
Journal: Antimicrob Agents Chemother Date: 2011-03-14 Impact factor: 5.191

3. Acute lymphocytic leukemia with superimposed invasive aspergillosis and pneumopericardium successfully treated with voriconazole.

Authors: Carlos L Alviar; Bryan Doherty; Muthiah Vaduganathan
Journal: Proc (Bayl Univ Med Cent) Date: 2014-07

Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.

Review 1. The clinical spectrum of pulmonary aspergillosis.

2. Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

3. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.

1. Human tissue distribution of voriconazole.

2. Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

3. Acute lymphocytic leukemia with superimposed invasive aspergillosis and pneumopericardium successfully treated with voriconazole.

4. Anidulafungin Pharmacokinetics in Ascites Fluid and Pleural Effusion of Critically Ill Patients.

Review 5. Tissue penetration of antifungal agents.

6. Candida Empyema Thoracis at Two Academic Medical Centers: New Insights Into Treatment and Outcomes.